Literature DB >> 21209777

Selectins as mediators of lung metastasis.

Heinz Läubli1, Lubor Borsig.   

Abstract

UNLABELLED: Lung metastasis remains the major cause of cancer related mortality in patients with breast, gastrointestinal, sarcoma, melanoma and kidney cancer. Here we characterize the expression of selectins during metastatic lung colonization and analyzed their function in the formation of pulmonary metastasis. E-selectin, together with VCAM-1, were detected 6 h after the microvascular arrest of tumor cells indicating an inflammatory activation of the local endothelial cells. No E-selectin expression was detected in pre-metastatic lungs of mice carrying primary tumors. P- and L-selectin were present during initiating steps of lung colonization and correlated with the recruitment of platelets and leukocytes to metastatic tumor cells. Experimental metastasis was significantly reduced in the absence of P- or L-selectin while no attenuation of metastasis was observed in E-selectin-deficient mice. Collectively, selectins are upregulated within the metastatic microenvironment of tumor cells and the formation of a permissive metastatic microenvironment is facilitated by P- and L-selectin mediated interactions between tumor cells and blood components. E-selectin does not affect metastatic initiation in the lung tissue and its expression rather indicates a local activation of lung microvascular endothelial cells. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s12307-010-0043-6) contains supplementary material, which is available to authorized users.

Entities:  

Keywords:  Carcinomas; Endothelium; Metastasis; Metastatic microenvironment; Selectins; Tumor microenvironment

Year:  2010        PMID: 21209777      PMCID: PMC2990482          DOI: 10.1007/s12307-010-0043-6

Source DB:  PubMed          Journal:  Cancer Microenviron        ISSN: 1875-2284


  52 in total

Review 1.  Tumor metastasis: mechanistic insights and clinical challenges.

Authors:  Patricia S Steeg
Journal:  Nat Med       Date:  2006-08       Impact factor: 53.440

Review 2.  Interaction of the hemostatic and immune systems in the metastatic spread of tumor cells.

Authors:  G J Gasic; G P Tuszynski; E Gorelik
Journal:  Int Rev Exp Pathol       Date:  1986

3.  Characterization of the host proinflammatory response to tumor cells during the initial stages of liver metastasis.

Authors:  Abdel-Majid Khatib; Patrick Auguste; Lucia Fallavollita; Ni Wang; Amir Samani; Maria Kontogiannea; Sarkis Meterissian; Pnina Brodt
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

4.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

Authors:  Sergei Grivennikov; Eliad Karin; Janos Terzic; Daniel Mucida; Guann-Yi Yu; Sivakumar Vallabhapurapu; Jürgen Scheller; Stefan Rose-John; Hilde Cheroutre; Lars Eckmann; Michael Karin
Journal:  Cancer Cell       Date:  2009-02-03       Impact factor: 31.743

Review 5.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

6.  Systemic spread is an early step in breast cancer.

Authors:  Yves Hüsemann; Jochen B Geigl; Falk Schubert; Piero Musiani; Manfred Meyer; Elke Burghart; Guido Forni; Roland Eils; Tanja Fehm; Gert Riethmüller; Christoph A Klein
Journal:  Cancer Cell       Date:  2008-01       Impact factor: 31.743

Review 7.  Heparins attenuate cancer metastasis: are selectins the link?

Authors:  Heinz Laubli; Lubor Borsig
Journal:  Cancer Invest       Date:  2009-06       Impact factor: 2.176

8.  P-selectin- and heparanase-dependent antimetastatic activity of non-anticoagulant heparins.

Authors:  Nina Hostettler; Annamaria Naggi; Giangiacomo Torri; Riva Ishai-Michaeli; Benito Casu; Israel Vlodavsky; Lubor Borsig
Journal:  FASEB J       Date:  2007-06-08       Impact factor: 5.191

9.  Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis.

Authors:  Eric Camerer; Aisha A Qazi; Daniel N Duong; Ivo Cornelissen; Rommel Advincula; Shaun R Coughlin
Journal:  Blood       Date:  2004-03-18       Impact factor: 22.113

10.  Redirection of tumor metastasis by expression of E-selectin in vivo.

Authors:  L Biancone; M Araki; K Araki; P Vassalli; I Stamenkovic
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

View more
  33 in total

1.  Conformational changes of 1-4-glucopyranosyl residues of a sulfated C-C linked hexasaccharide.

Authors:  Alessia Coletti; Stefano Elli; Eleonora Macchi; Patrizia Galzerano; Leila Zamani; Marco Guerrini; Giangiacomo Torri; Elena Vismara
Journal:  Carbohydr Res       Date:  2014-02-25       Impact factor: 2.104

Review 2.  Cyclooxygenases and lipoxygenases in cancer.

Authors:  Claus Schneider; Ambra Pozzi
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

3.  Holothurian glycosaminoglycan inhibits metastasis via inhibition of P-selectin in B16F10 melanoma cells.

Authors:  Zhiqiang Yue; Aiyun Wang; Zhijie Zhu; Li Tao; Yao Li; Liang Zhou; Wenxing Chen; Yin Lu
Journal:  Mol Cell Biochem       Date:  2015-08-30       Impact factor: 3.396

Review 4.  Sialic acid-binding immunoglobulin-like lectins (Siglecs) detect self-associated molecular patterns to regulate immune responses.

Authors:  Heinz Läubli; Ajit Varki
Journal:  Cell Mol Life Sci       Date:  2019-09-04       Impact factor: 9.261

5.  Fluorometric Quantification of Single-Cell Velocities to Investigate Cancer Metastasis.

Authors:  Erin Elizabeth Edwards; Katherine Gayle Birmingham; Meghan Jeanne O'Melia; Jaeho Oh; Susan Napier Thomas
Journal:  Cell Syst       Date:  2018-11-07       Impact factor: 10.304

6.  Sulfated hexasaccharides attenuate metastasis by inhibition of P-selectin and heparanase.

Authors:  Lubor Borsig; Israel Vlodavsky; Rivka Ishai-Michaeli; Giangiacomo Torri; Elena Vismara
Journal:  Neoplasia       Date:  2011-05       Impact factor: 5.715

7.  Elevated serum levels of sialyl Lewis X (sLeX) and inflammatory mediators in patients with breast cancer.

Authors:  Evan N Cohen; Tamer M Fouad; Bang-Ning Lee; Banu K Arun; Diane Liu; Sanda Tin; Angelica M Gutierrez Barrera; Toshihide Miura; Iwao Kiyokawa; Jun Yamashita; Ricardo H Alvarez; Vicente Valero; Wendy A Woodward; Yu Shen; Naoto T Ueno; Massimo Cristofanilli; James M Reuben
Journal:  Breast Cancer Res Treat       Date:  2019-05-03       Impact factor: 4.872

8.  Lung-derived factors mediate breast cancer cell migration through CD44 receptor-ligand interactions in a novel ex vivo system for analysis of organ-specific soluble proteins.

Authors:  Jenny E Chu; Ying Xia; Benjamin Chin-Yee; David Goodale; Alysha K Croker; Alison L Allan
Journal:  Neoplasia       Date:  2014-02       Impact factor: 5.715

9.  Molecular MRI enables early and sensitive detection of brain metastases.

Authors:  Sébastien Serres; Manuel Sarmiento Soto; Alastair Hamilton; Martina A McAteer; W Shawn Carbonell; Matthew D Robson; Olaf Ansorge; Alexandre Khrapitchev; Claire Bristow; Lukxmi Balathasan; Thomas Weissensteiner; Daniel C Anthony; Robin P Choudhury; Ruth J Muschel; Nicola R Sibson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

10.  Nanoscale Tuning of VCAM-1 Determines VLA-4-Dependent Melanoma Cell Plasticity on RGD Motifs.

Authors:  Katharina Amschler; Eugen Kossmann; Luise Erpenbeck; Sebastian Kruss; Tillmann Schill; Margarete Schön; Sigrid M C Möckel; Joachim P Spatz; Michael P Schön
Journal:  Mol Cancer Res       Date:  2017-12-08       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.